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GENERAL INTRODUCTION 
over the past decade numerous studies have focused on the 
role of cytokines in physiological and pathological processes. 
Cytokines regulate immune and inflammatory responses and may 
also be involved in coordinating the immune system with other 
systems of the body. The rapid expansion of research in 
cytokine biology has been facilitated by the development of 
methods to analyze cytokine production. However, obtaining 
meaningful data from any one technique is difficult because 
each method is hampered by inherent limitations. Therefore, 
sufficient knowledge of each method's capabilities and 
limitations is necessary when choosing between techniques 
available for studying cytokines. In addition, the continued 
development of new and improved methods and reagents for 
evaluating cytokine production is necessary. This is 
especially true in the area of veterinary research where the 
study of cytokines in domestic animals has been limited by the 
lack of species-specific reagents. 
Explanation of Thesis Format 
This thesis is composed of two papers and a brief 
summary. The first paper is an examination of the most 
commonly used methods of analyzing cytokines with a focus on 
each method's capabilities and limitions. This portion of the 
thesis is written in the form of a review paper (Paper I). In 
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the second part of the thesis, I have addressed the need for 
species-specific reagents for studying cytokines in domestic 
animals by using the reverse transcription-polymerase chain 
reaction to develop nucleic acid probes that are specific for 
cytokines in cattle. This technique was also used to study the 
expression of bovine cytokine genes in mitogen stimulated 
peripheral blood mononuclear cells (Paper II). The work 
reported in the second paper has been submitted for 
publication. 
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PAPER I. ADVANTAGES AND DISADVANTAGES OF THE COMMONLY USED 
METHODS FOR ANALYZING CYTOKINES 
4 
INTRODUCTION 
Cytokines are a group of small molecular weight proteins 
that are secreted primarily by cells of the immune system and 
play a central role in regulating immune and inflammatory 
responses. These molecules have pleiotropic and often 
overlapping biological effects on lymphoid and non-lymphoid 
cells (Benveniste and Merrill, 1986; Thornhill et al., 1990, 
Last-Barney et al., 1988). Cytokines may also be involved in 
integrating the immune system with other systems of the body 
(Frei et al., 1989; Breder et al., 1988). Over the past 
decade, numerous studies have focused on the role of cytokines 
in physiological and pathological processes. 
Cytokines were first identified by their biological 
activity that was usually present in complex biological fluids 
(Gery and Waksman, 1972; Gordon and MacLean, 1965; Howard et 
al., 1982). This resulted in confusion and redundancy in 
assigning functions and names to the myriad of cytokines and 
their activities. In the last ten years advancements in 
protein purification, recombinant DNA technology and 
monoclonal antibody production have converted the confusing 
collection of cytokines into well-defined proteins with known 
activities. 
The technological advances of the last decade have also 
produced reagents necessary for advancing the study of 
cytokine biology. The availability of recombinant cytokines 
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has allowed researchers to definitively determine the biologic 
role of cytokines and to evaluate their potential as 
therapeutic agents. Purified cytokines have also lead to the 
development of cytokine-specif ic antibodies and cytokine-
responsive cell lines. In addition, molecular techniques have 
produced cytokine-specific nucleic acid probes. These reagents 
have allowed the development of a wide variety of methods for 
studying cytokines. 
Obtaining meaningful data about cytokine production from 
any one technique is difficult because each method is hampered 
by inherent limitations. The selection of appropriate methods 
of cytokine analysis for a particular research objective is 
important and requires a working knowledge of each technique. 
This paper is a review of the capabilities and limitations of 
the most commonly used techniques of cytokine analysis. 
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NATURAL AND RECOMBINANT CYTOKINES 
A prerequisite for developing cytokine assays is the 
availability of purified cytokines. These preparations are 
needed to develop various assay reagents, standards, and 
radioactive compounds. Ideally, the purified cytokine should 
be identical to the endogenous cytokine for which the assay is 
intended to measure, but practical considerations prevent this 
in many cases (Chard, 1982). Purifying cytokines from natural 
sources is time-consuming and labor-intensive and is not a 
practical alternative for most laboratories. Cytokines 
isolated from humans and laboratory animals have been prepared 
by several methods and are available commercially. These 
include cytokines isolated from natural sources and 
recombinant products expressed in prokaryotic and eukaryotic 
systems. The type of cytokine necessary for developing and/ or 
conducting an assay depends on the type of assay. 
Biologically active cytokines are required for developing 
cytokine biologic assays. The cytokines are necessary when 
cloning and maintaining cytokine-responsive target cell lines 
and they are needed to generate standard curves when 
conducting the assays. Cytokines isolated from natural sources 
are ideal for this application but suffer from two 
limitations. These preparations often contain trace amounts 
of other proteins that may interfere in the assay (Thurman et 
al.; 1986; Mier et al., 1985), and the elaborate purification 
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schemes that are used to obtain these products can affect 
their activity (Thurman et al., 1986; Smith et al., 1983). 
Recombinant cytokines offer an attractive alternative 
because they are available in highly purified and biologically 
active forms. Most recombinant cytokines produced in 
prokaryotic expression systems maintain their biologic 
activity even though they are not glycosylated (Casagli et 
al., 1989; Tocci et al., 1987; March et al., 1985). These 
preparations give satisfactory results in most bioassays. 
However, an ever increasing number of recombinant cytokines 
are being expressed in eukaryotic systems because they are 
glycosylated in a manner comparable to the naturally occurring 
form. These recombinant products may or may not differ 
functionally from naturally occurring glycosylated cytokines 
or non-glycoslyated cytokines that are expressed in 
prokaryotic systems (Casagli et al., 1989). Information 
concerning the biologic activity of these products is usually 
provided by the manufacturer. 
The type of cytokine preparation used for making 
antibodies to be used in cytokine irnmunoassays depends largely 
on whether polyclonal or monoclonal antibodies are being 
produced. Cytokines isolated from natural sources are 
antigenically analogous to the cytokines that are to be 
assayed, and therefore they are ideal irnmunogens for producing 
antibodies . However, the impurity of these preparations 
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increases the likelihood of obtaining cross-reacting 
imrounoglobins when producing polyclonal antibodies (Tijssen, 
1985, Auron et al., 1984; Mier et al . , 1985; Thurman et al., 
1986). This is not a concern when producing monoclonal 
antibodies since cross-reacting antibodies can be eliminated 
when screening and selecting the antibody-producing clone 
(Tijssen, 1985). 
Recombinant cytokines are highly purified, but there is a 
potential risk in using these products to generate antibodies. 
Recombinant cytokines may differ antigenically from the 
naturally occurring cytokines because of differences in post-
translational processing and conformational structure 
(Rafferty et al., 1991; Peppard et al., 1992; Thurman et al., 
1986). Antibodies produced against a recombinant product may 
not bind to the naturally occurring protein. Therefore, 
antibodies must be chosen that recognize epitopes shared by 
the recombinant and natural cytokines (Gaffney et al., 1987; 
Abrams and Pearce, 1988; Sato et al., 1986). 
Purified cytokine preparations for humans and laboratory 
animals have been widely developed and are available 
commercially. However, this is not the case for cytokines from 
other species. This has severely limited the development of 
cytokine assays for other species including domesticated 
animals. Several cytokine genes in pigs and cattle have been 
cloned (Blecha, 1991), although the recombinant products are 
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not yet commercially available. This situation may improve as 
the study of cytokines in domestic animals progresses. 
Fortunately, cytokines exhibit varying degrees of cross-
species reactivity and many human and murine cytokines have 
been found to be biologically active on cells from other 
species (Fong and Doyle, 1986; Stott et al., 1986; Nagi and 
Babiuk, 1989). Therefore, murine and human cytokines can 
sometimes be used to develop and conduct cytokine assays for 
other species when homologous cytokine preparations are not 
available. 
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BIOASSAYS 
Bioassays detect cytokines by assessing their biologic 
affect on an indicator cell population. Because cytokines are 
potent effector molecules, bioassays are a sensitive method of 
detecting cytokines and are usually used to measure cytokines 
that are present in body fluids and culture supernatants. 
Numerous cytokine bioassays have been described and many are 
able to detect cytokines in the sub-picomolar range (Eskandari 
et al., 1990; Orencole and Dinarello, 1989). 
Cytokine bioassays take advantage of each cytokine's 
unique functional properties and therefore differ markedly 
depending on the cytokine being studied . In addition, some 
cytokines can be analyzed in a variety of ways because of the 
pleiotropic nature of their bioactivity (Falk et al., 1987; 
Conlon, 1983; Gillis and Mizel, 1981). Despite this diversity, 
many cytokines are assayed by their ability to stimulate cell 
proliferation. Bioassays have also been developed that measure 
other cytokine-induced responses. For example, tumor necrosis 
factor is assayed by its ability to lyse tumor cell lines 
(Espevik and Nissen-Meyer, 1986; Eskandari et al., 1990). The 
neutrophil activator, IL-8, can be detected by its affect on 
specific neutrophil functions (Matsushima and Oppenheim, 
1989). 
Most biological assays require the measurement of 
surviving and/or proliferating mammalian cells. This can be 
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accomplished by several methods including counting viable 
cells, measuring released 51Cr-labeled protein after cell lysis 
(Zheng et al., 1990), and measuring the incorporation of 
radioactive nucleotides (Gillis et al., 1978). Another 
alternative is to pulse the cells with the tetrazolium 
compound 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT). This compound is converted by viable cells to a 
colored product that can be quantitated spectrophotometrically 
(Mosmann, 1983). When combined with limiting dilution 
techniques and probit analysis, cytokine biologic assays allow 
the accurate quantitation of cytokine activity (de St. Groth, 
1982: Jordan, 1972). 
Clonally-derived cells lines are preferred as indicator 
cells in bioassays because they provide a homogeneous, well-
characterized, population of cells that give a uniform 
response. The availability of purified cytokines has 
facilitated the isolation and cloning of numerous cytokine-
responsive cell lines (Gillis and Mizel, 1981; Gillis et al., 
1978: Ihle et al., 1982: Hu-Li et al., 1989; Lansdorp et al., 
1986 ) . Some of these cell lines can be purchased for a minimal 
price from the American Type Culture Collection (ATCC, 
Rockville, Maryland). 
Although it has been demonstrated that cytokines are a 
highly conserved group of molecules, they still exhibit 
varying degrees of species-specificity (Olsen and Stevens, 
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1993; Rot, 1991; Goodwin et al., 1989). For optimum responses 
in bioassays, indicator cells from the same species as the 
cytokine to be assayed should be used. This is rarely a 
problem when developing bioassays for measuring human or 
laboratory animal cytokines since indicator cell lines and 
neutralizing antibodies for these species have been 
extensively developed and are commercially available. These 
reagents are not as abundant for other species, and this can 
pose a problem when developing bioassays to measure cytokines 
in domestic animals. Generally, investigators wishing to 
measure cytokines from these species must either use 
heterologous cell lines and antibodies or assume the laborious 
task of developing these reagents themselves. 
A major disadvantage associated with bioassays is their 
lack of specificity. Samples that are assayed for a specific 
cytokine often contain other biologically active molecules 
that may have stimulatory or inhibitory affects on the 
indicator cell lines that are used in the assay (Ranges et 
al., 1988; Helle et al., 1988; Baker et al ., 1981) . Many 
assays that were once thought to be specific for a certain 
cytokine have now been shown to respond to other cytokines. 
For example, several cells lines that have been used to assay 
for IL-2, such as CTLL2 and HT-2, have been found to also 
proliferate to IL-4 (Grabstein et al., 1986; Ho et al., 1987). 
In some cases, contaminating substances have an antagonistic 
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effect on the target cell response (Gajewski and Fitch, 1990; 
Tilden and Balch, 1982). These studies and numerous others 
make it apparent that bioassays are of limited utility unless 
steps are taken to demonstrate their specificity. 
The most effective way to demonstrate the specificity of 
a bioassay is to use neutralizing antibodies. These are either 
monoclonal or polyclonal antibodies raised against a cytokine 
that bind to the active site on the molecule and inhibit its 
activity (Brown et al., 1990). The antibody is added to the 
test sample and the ability of the antibody to negate the 
activity in the sample demonstrates the cytokine specificity 
of the response. Similarly, antibodies to cytokines that are 
known to interfere in the assay can be used to eliminate the 
interfering activity and allow the cytokine of interest to act 
on the target cells (Ohara and Paul, 1985). In addition, 
soluble cytokine receptors, antibodies to cytokine receptors 
and cytokine receptor antagonists have also been used to block 
cytokine/receptor binding and thereby neutralize cytokine 
bioactivity (Sheehan et al., 1988; Fanslow et al., 1991; 
Estrov et al., 1992). 
Another disadvantage of bioassays is that they can only 
detect extracellular, biologically active cytokines. While 
most cytokines are secreted proteins, biologically active, 
membrane-bound forms of some cytokines have been identified 
(Kriegler et al., 1988; Kurt-Jones et al., 1985; Peck et al., 
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1989). In addition, internalization of the cytokine/receptor 
complex is necessary for the activation of many cytokine 
responsive cells (Smith, 1988; Lowenthal and MacDonald, 1986). 
This process removes cytokines from solution and precludes 
them from being detected in bioassays. Consequently, bioassays 
may underestimate the amount of cytokines being produced by 
cells by not detecting cell-associated molecules. 
Another characteristic of bioassays that limit their use 
in many situations is that they require the technical skill, 
equipment, and reagents that are necessary for maintaining 
mammalian cell cultures. The indicator cells must be passed to 
fresh media at regular intervals and they must be grown in 
sufficient quantities when conducting the assays. Furthermore, 
some cell lines may require special media additives for 
optimal growth and/ or viability. These culture manipulations 
and reagents that are required to conduct cytokine bioassays 
can be time-consuming and expensive. 
In summary, bioassays can be a very sensitive and 
quantitative means of measuring extracellular, biologically-
active cytokines. The disadvantages of these assays are that 
they can be technically difficult and expensive to complete 
and measures must be taken to demonstrate their specificity. 
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IMMUNOASSAYS 
The production and characterization of antibodies to 
cytokines has facilitated the development of a variety of 
antibody-based assay techniques. These methods take advantage 
of the antigen/antibody bond which allows the accurate 
identification and discrimination of the antigen (i.e. 
cytokine) in complex mixtures of proteins. Cytokine 
immunoassays are sensitive, specific, and can give 
quantitative results without the technical difficulties that 
are associated with bioassays. 
The most critical parameter in developing a cytokine 
immunoassay is the development of appropriate antibodies. The 
sensitivity of immunoassays has been shown to vary 
dramatically depending on the affinity and specificity of the 
antibodies used (Brown et al., 1990; Schumacher et al., 1988). 
All antibodies must be rigorously screened by western blotting 
for cross-reactivity and non-specific binding to other 
molecules. Both polyclonal and monoclonal antibodies have been 
successfully used in cytokine immunoassays (Wadhwa et al., 
1990; DeForge and Remick, 1991; Gaffney et al., 1987). 
However, there are several factors to consider when choosing 
between these two reagents. 
Monoclonal antibodies are produced by a single B cell 
clone and are therefore highly specific and are free of 
irrelevant immunoglobins. In addition, they can be produced in 
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virtually unlimited quantities with predictable and 
reproducible specificities and affinities (Campbell, 1984). As 
mentioned earlier, purity of the immunizing cytokine 
preparation is not critical because non-specific antibodies 
are eliminated during selection and cloning. The disadvantages 
associated with monoclonal antibodies are that they are time-
consuming and expensive to produce and their affinity may be 
too low for successful use in binding assays (Campbell, 1984). 
The generation of polyclonal antibodies requires a highly 
purified immunogen since antibodies raised against the 
impurities are not eliminated and they may interfere in the 
assay (Tijssen, 1985). Even when a pure immunogen is used, 
cross-reacting antibodies can still be a problem if the 
cytokine shares structural homology with other proteins (Auron 
et al., 1984; Dinarello et al, 1977). Furthermore, obtaining 
reproducible reagents is difficult because of the variation in 
immune responses between animals. (Tijssen, 1985). Despite 
these problems, there are some advantages to using polyclonal 
antibodies in cytokine immunoassays. The many different 
epitopes involved in cytokine/antibody binding creates an 
additive effect and results in a high affinity reaction. In 
addition, polyclonal antibodies are easy and inexpensive to 
develop (Campbell, 1984). 
Like bioassays, cytokine immunoassays only detect 
secreted cytokines. However, unlike bioassays, immunoassays do 
17 
not require the cytokine to be functional in order to be 
detected. Consequently, immunoassays may detect inactive 
cytokines, cytokine precursors or cytokine break-down products 
that still maintain their structural epitopes but are not 
biologically active (Jaattela et al., 1988). This may result 
in overestimating the amount of biologically active cytokines 
that are present in the assayed sample. Running concurrent 
bioassays is one way of ensuring that the immunoassays are 
detecting biologically active cytokines (Rampart et al., 1992; 
van der Meer et al., 1988; Jaattela et al., 1988; Wadhwa et 
al., 1990). 
The most common immunoassays that are used in cytokine 
research are the enzyme-linked immunosorbent assay (ELISA) 
and the radioimmunoassay (RIA). 
Enzyme-linked Immunosorbent Assay 
This technique, originally described by Engvall and 
Perlmann (1971), has proven invaluable for detecting and 
quantifying antibodies in serum, hybridoma supernatants, and 
ascites fluids. Modifications of the original format have 
allowed this method to be used for measuring antigens that are 
present in biological fluids (Tijssen, 1985). ELISA's are 
rapidly replacing most other immunoassays in both clinical and 
research laboratories because they are fast, easy to conduct, 
give quantitative results, and require a minimum of reagents 
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and equipment. 
The ELISA techniques that are used in most cytokine 
assays rely on the use of a cytokine specific-antibody that 
selectively binds to the cytokine of interest. A direct or 
indirect method of detecting the cytokine can be used. In the 
direct method, the cytokine-specific antibody is conjugated to 
an enzyme. In the indirect method, the cytokine-specific 
antibody is unlabelled and a second labelled antibody is used 
to bind to the first antibody {Carson, 1990). 
After antigen/antibody binding the conjugated enzyme 
cleaves a substrate to generate a colored reaction product 
that is soluble and can be detected spectrophotometrically. 
The absorbance of the colored solution is proportional to the 
amount of cytokine present in the test sample. ELISA'S are 
routinely conducted in 96-well microtiter plates using serial 
dilutions of the test sample. Data is collected by using a 
microtiter plate reader that measures the absorbance of the 
solutions contained in the individual microtiter plate wells 
(Tijssen, 1985). 
ELISA's are termed a solid phase immunoassay because 
either the antigen or antibody is attached to the microtiter 
plate wells. The two types of ELISA techniques that are used 
most frequently in measuring cytokines are the direct and 
capture or sandwich ELISA. These two methods differ in how the 
antigen is immobilized onto the microtiter plates. The direct 
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ELISA involves binding serial dilutions of the cytokine-
containing sample directly to microtiter wells. The capture 
ELISA binds the cytokine to the plates by "capturing" it with 
a cytokine-specific antibody that is bound to the microtiter 
well. 
The capture ELISA has been shown to be more sensitive 
because this method selectively absorbs the cytokine to the 
plates; thus eliminating contaminating and possibly cross-
reacting material (DeForge and Remick, 1991). The capture 
ELISA requires two antibodies that bind two separate epitopes 
so that the capture antibody and the enzyme-linked antibody 
can bind the cytokine simultaneously. These requirements can 
be satisfied with one or two polyclonal (Gaffney et al., 
1987), two monoclonal (Schumacher et al., 1988; Andersson et 
al., 1989) or a combination of polyclonal and monoclonal 
antibodies (Wadhwa et al., 1990; Ko et al., 1992). Most 
commercially available cytokine ELISA "ki ts" use the capture 
or sandwich format and they have a detection limit of 
approximately 10 picograms. However, the sensitivity of the 
assays may vary depending on the complexity of the assayed 
samples (Andersson et al., 1989). 
ELISA test kits and reagents for detecting human and 
laboratory animal cytokines have been extensively developed 
and many are commercially available. Similar kits and reagents 
for detecting cytokines in domestic animals are not as readily 
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available exc ept for one commercially-produced kit for 
detecting bovine interferon-y. ELISA'S developed for the 
detection of cytokines in one species may or may not function 
in other species since cytokine-specif ic antibodies have been 
shown to exhibit species-specificity (Schumacher et al., 
1988). Manufacturers often provide information on whether or 
not their reagents and/ or kits can be used to measure 
cytokines in other species. 
Radioimmunoassay 
Radioimmunoassays were first developed for the 
quantitation of insulin in serum (Yallow and Berson, 1960) and 
historically have been used in the field of endocrinology for 
the sensitive detection of peptide hormones. In the last 
decade, with the availability of purified cytokines and 
cytokine specific-antibodies, sensitive radioimmunoassays have 
been developed for use in cytokine research. 
RIA's are liquid-phase antibody-based assays that belong 
to a series of related techniques called binding assays. 
Binding assays involve quantitating a ligand in solution by 
allowing the ligand to saturate a specific binder and then 
determining the distribution of the ligand between the bound 
and free phases (Chard, 1982). In the case of the RIA ' s for 
cytokines, the cytokine acts as the ligand, or substance to be 
measured, and an antibody specific for the cytokine serves as 
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the binder. Also included in the assay is a tracer or known 
amount of purified radio-labelled cytokine which allows 
quantitating the amount of cytokine between the bound and free 
states (Poole et al., 1989; Rampart et al., 1992). The amount 
of radioactivity in the bound state is inversely proportional 
to the amount of cytokine in the test sample. A standard curve 
of purified unlabelled cytokine is included in the assay and 
unknown samples are quantified by regression analysis (Chard, 
1982). 
RIA's are a very sensitive and quantitative method of 
analyzing cytokines in biological fluids. The reported 
sensitivities for RIA's vary, but most systems can detect 
cytokines in the nanomolar range (Poole et al, 1989; Rampart 
et al., 1992; van der Meer et al, 1988). Some commercially 
available cytokine RIA kits are able to detect c ytokines in 
the picogram range, although the sensitivity may vary 
depending on the nature and complexity of the test solution. 
Some companies report that RIA's are less sensitive when 
assaying serum as opposed to culture supernatants . 
The one major disadvantage of RIA's is that it requires 
the use of radioisotopes which necessitates the safe handling 
of reagents and the proper disposal of radioactive waste. In 
addition, radio-labelled tracers must be frequently prepared 
because of the short half-life of some of the commonly used 
isotopes. These precautions and considerations associated with 
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the use of radioisotopes can make RIA's inconvenient to 
conduct. 
In summary, obtaining antibody preparations that are 
appropriate for use in immunoassays is the major limiting 
factor in developing these techniques for cytokine analysis. 
These methods do not discriminate between biologically active 
and inactive cytokines and they detect only extra-cellular 
cytokines. However, they do offer a convenient, reliable 
method of cytokine analysis that can give sensitive, specific 
and quantitative results. 
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TRANSCRIPT ANALYSIS 
Transcript analysis monitors cytokine production by using 
nucleic acid hybridization methodology to detect cytokine-
specif ic mRNA molecules. Most cytokine genes are not 
constitutively expressed and have been shown to be regulated 
at the transcriptional (Fenton et al., 1987; Servan-Chiara et 
al., 1986) and post-transcriptional levels (Sariban et al., 
1988; Zuckerman et al., 1991; Bickel et al., 1990). The 
presence of cytokine-specif ic mRNA molecules in a cell is 
indicative of the level of cytokine gene expression and can 
provide information about the regulation of cytokine 
production. 
Transcript analysis uses sequence-specific nucleic acid 
probes that recognize and bind to mRNA molecules that bear a 
complementary nucleotide sequence (Sambrook et al., 1989). 
Effective nucleic acid probes can be single or double 
stranded, RNA or DNA. The probes vary in length depending on 
the technique being used (Keller and Manak, 1989). The unique 
nucleotide sequence of the probe confers its specificity to 
the target mRNA molecules and allows the detection of minute 
amounts of target mRNA molecules in complex mixtures of 
macromolecules. 
Analysis of cytokine mRNA is usually performed with the 
assumption that the defined levels of cytokine mRNA expression 
correspond to certain degrees of cytokine production. This 
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correlation has been proven in many instances. However, 
cytokine production can also be regulated post-
transcriptionally and in these instances the presence of 
cytokine mRNA may not be correlated with cytokine production 
and secretion (Chantry et al., 1989; Nguyen et al., 1990; 
Descoteaux and Matlashewski, 1990). Therefore, evaluating 
cytokine production solely on the basis of cytokine-specif ic 
mRNA expression may give erroneous results concerning the 
amount of biologically active cytokine that is being secreted 
by the cells. 
The most extensive cloning of cytokine genes has been 
done in humans and laboratory animals and this has resulted in 
a wide range of probes that are available for cytokine 
transcript analysis in these species. The cloning of cytokine 
genes in domestic animals has been relatively limited. Few 
cytokine genes have been cloned in cattle, pigs, and sheep 
(reviewed in Blecha, 1991), and the unavailability of species-
specific probes has hampered progress in studying the 
transcription of cytokine genes in these domestic animals. 
Sufficient homology often exists between cytokine genes of 
different species to allow the use of heterologous probes in 
detecting cytokine transcripts (Jensen and Schultz, 1991; 
Stevens et al., 1992). However, the imperfect homology 
detracts from the specificity and sensitivity of the probes 
(Sambrook et al., 1989). 
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Most methods of transcript analysis require RNA to be 
isolated from cells. The unique characteristics of cytokine 
gene transcripts and gene expression pose several problems in 
accomplishing this task. First of all, cytokine gene 
expression is often a transient event which requires cells or 
tissue samples to be taken at frequent intervals (Weinberg et 
al., 1990; Shaw et al., 1988 ) . Secondly, while all RNA 
requires special handling because of its susceptibility to 
degradation by nucleases, many cytokine mRNA's contain highly 
conserved AU-rich regions that make these molecules extremely 
unstable (Shaw and Kamen, 1986; Caput, 1986). Thirdly, many 
cytokines are expressed at low levels and often by only a few 
cells (Hutchings et al., 1989; Powers et al ., 1988). 
Therefore, cytokine transcripts can be lost in the noise of 
the many times more numerous background cells that are not 
expressing the target gene. Consequently, the analysis of 
these transcripts requires isolating large quantities of RNA 
and using highly sensitive detection methods. 
Methods of transcript analysis can be divided into two 
general categories based on whether the analyzed RNA is fixed 
to a solid support or is in solution. Northern and dot-blot 
hybridization require that the RNA is fixed to a membrane 
while the nuclease protection assay and RT-PCR are solution 
hybridization techniques. 
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Northern Blots 
Northern blotting is widely used for the analysis of gene 
expression and has been extensively used in cytokine research. 
This technique can provide qualitative and semi-quantitative 
information about the relative abundance of specific mRNA 
molecules. In addition, it is also useful in demonstrating the 
transcript specificity of nucleic acid probes. 
Northern blotting involves the transfer of RNA that has 
been size fractionated by electrophoresis to a solid support 
membrane. The RNA is permanently fixed to the membrane and the 
membrane is incubated in a solution containing a labelled 
probe that is specific for the target mRNA molecule . After the 
probe is allowed to bind to the RNA, the support membrane is 
washed extensively to remove non-specific probe binding, and a 
detection system is used to visualize the probe/ transcript 
complex. The approximate size of the detected transcript can 
be determined by including RNA molecular weight size standards 
in the assay (Sambrook et al., 1989). 
The probes used in northern blots can be labelled in a 
variety of ways. The most commonly used method involves 
labelling the probes with a radioisotope such as 32phosphorus 
(Keller and Manak, 1989). The probe is detected by exposing 
the membrane to X-ray film. In addition to being very 
sensitive, the use of radioactive probes allows the membrane 
to be stripped of one probe and re-hybridized to a different 
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probe (Sambrook et al., 1989). Several non-radioactive methods 
of labelling and detecting nucleic acid probes are also 
available. These include biotin-avidin linked enzyme detection 
systems, and enzyme-linked antibody detection systems (Langer 
et al., 1981; Raap et al., 1989). These methods are safer and 
more convenient than radioactive labelling methods, but they 
are less sensitive and do not allow the membrane to be 
stripped and re-probed with a different probe (Ambros and 
Karlie, 1987). 
Detecting low abundance cytokine mRNA can be a problem 
when using northern blots, even when using highly sensitive 
probes. In order to provide sufficient cytokine mRNA for 
detection using this method large amounts of RNA must be 
electrophoresed and transferred to the membrane. As much as 10 
to 20 µg of total RNA is often required for detection of some 
cytokine mRNAs (Stabel et al., 1993; Weinberg et al., 1990). 
Extractions on this scale require large quantities of starting 
material, which may preclude the use of this technique in 
situations where tissue samples are small. 
The sensitivity of northern blots can be improved by 
isolating mRNA from the total RNA preparations (Sambrook et 
al, 1989). This procedure eliminates other RNA species from 
the preparation and makes the mRNA more accessible for 
hybridization. mRNA can be isolated from other RNA species by 
oligo(dt) cellulose chromatography (Aviv and Leber, 1972). 
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mRNA isolation may increase the sensitivity of northern blots, 
but the extra purification step also significantly reduces the 
amount of usable RNA that is obtained from a given amount of 
cells or tissue. Several papers have reported greater 
sensitivity in blot-hybridization analyses when single-
stranded RNA probes are used instead of the commonly used 
double-stranded DNA probes (Cerretti et al., 1986; Melton et 
al., 1984). 
In addition to problems with sensitivity, another 
disadvantage of northern blot analysis is that quantitative 
data is difficult to obtain. This is partially due to the 
problems associated with accurately quantifying RNA and 
achieving uniform loading of agarose gels. One method that has 
been used to address this problem is to compare the transcript 
levels for the cytokine mRNA to the transcript level of a 
''house keeping" or control gene on the same blot. Probes 
specific for B-Actin (Stabel et al., 1993), glyceraldehyde 3-
phosphate dehydrogenase (Zentella et al., 1991), and ribosomal 
RNA species (Chantry et al., 1989) are commonly used in 
northern blots as control genes. The control gene is assumed 
to be expressed at a constant level and the data obtained for 
the cytokine transcript is normalized to that of the control 
transcript. 
The major criticism of using this approach is that the 
control gene must be expressed at a constant level under all 
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conditions that are used in the study. This is difficult to 
prove since quantitatively measuring the expression of control 
genes is inherently difficult. Indeed, the expression of the 
commonly used control gene, 8-actin, has been found to 
fluctuate in lymphoid cells under a variety of stimuli 
(Siebert and Fukuda, 1985; Degen et al., 1983). Therefore, if 
data for a cytokine transcript is to be normalized to a 
control gene, the expression of the control gene must be 
rigorously checked for consistent expression under all 
conditions that are used in the study. 
Two methods are available for assigning numerical values 
to hybridization signals that are obtained from northern 
blots. The most sensitive technique involves excising the 
portion of the membrane containing the hybridized probe and 
counting it in a scintillation counter (Stabel et al . , 1993). 
A second method uses a densitometer to quantify the 
hybridization signals on autoradiographs or directly on 
membranes if an enzyme-based detection system is used ( Nguyen 
et al., 1990). Both methods assign numeric values to the 
hybridization signals based on the intensity of the bands and 
they allow comparisons between the relative amounts of 
specific mRNA molecules that are present in the samples . 
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Dot Blots 
This method of transcript analysis is similar to northern 
blots in that RNA is attached to a solid support for 
hybridization, but differs in that the electrophoretic 
separation and transfer steps are omitted. The RNA is spotted 
directly onto the membrane usually with the aid of a vacuum 
manifold that has wells to contain each sample (Sambrook et 
al., 1989). There are several manifolds commercially available 
with different sizes, shapes and arrangements of the wells. 
This technique may also be ref erred to as spot or slot 
hybridization depending on the shape of the wells in the 
manifold. 
While similar in principle to northern blots, dot blots 
offer some advantages over northern blots. The obvious 
advantage is the time savings involved in eliminating the RNA 
electrophoresis step. RNA losses that occur during gel 
blotting can also be avoided. Moreover, the discrete dot (or 
slot) hybridization signals obtained with the dot-blot method 
are more conducive to quantitation using either densitometry 
or scintillation counting than the broad and often diffuse 
bands that are obtained with northern blots (Shaw et al., 
1988; Kronke et al., 1985). 
The major disadvantage associated with the dot-blot 
technique is the occurrence of non-specific binding of the 
probe to other molecules that are contained in the spotted 
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sample. Non-specific binding of the probe is not easily 
detected, because the sample is not size-fractionated by 
electrophoresis as is done in northern blots. Therefore, 
probes used in dot-blot analysis must be carefully checked for 
specificity using northern blots prior to use in dot blots. 
Furthermore, RNA samples used in dot-blots must be completely 
void of contaminating DNA. Since electrophoresis is not 
performed in dot-blots, any contaminating DNA will not be 
separated from RNA and the DNA will also bind to the probe. 
Nuclease Protection Assay 
Nuclease protection assays are a type of solution 
hybridization technique that was first described by Berk and 
Sharp (1978) for studying RNA splicing in viruses. Other names 
for this technique include Sl mapping, and RNase protection 
and Sl nuclease protection assay. The variety of different 
names for this method are derived from the type of nuclease 
(Sl nuclease or RNase) that is used and because this technique 
was originally developed to study or "map" gene and mRNA 
structure. 
This technique is called a solution hybridization 
technique because the probe and rnRNA are allowed to hybridize 
while in solution. After hybridization, the reaction is 
digested with a nuclease that specifically degrades single-
stranded nucleic acids. Being double stranded, the probe/rnRNA 
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complex is left intact and is detected by gel electrophoresis 
and/or autoradiography (Sambrook et al., 1989). 
Nuclease protection assays were first developed using 
double stranded DNA probes, but great improvements have been 
made with the use of single-stranded RNA probes (Williams et 
al., 1986). Single-stranded RNA probes eliminate the competing 
re-annealing reaction that occurs between the two strands of a 
double-stranded probe (Melton et al., 1984). Moreover, RNA 
probes form a RNA:RNA duplex with the mRNA that is more stable 
and less prone to artifacts when digested with RNase (Casey 
and Davidson, 1977). With the development of cloning vectors 
that facilitate the production of single-strand, labelled RNA 
probes (Melton et al., 1984), the "RNase protection assay" has 
become the nuclease protection assay of choice in detecting 
specific mRNA molecules. 
Semi-quantitative information can be obtained from RNase 
protection assays, although this technique is subject to the 
same limitations as northern blots. Accurately quantitating 
and aliquoting RNA samples is crucial to making sample to 
sample comparisons, and as with northern blots a control 
transcript is often used to normalize the data for sample 
variations. Quantitation of the hybridization signals can be 
accomplished by scanning autoradiographs with a densitometer 
or by excising the probe/transcript band from the gel and 
counting it in a scintillation counter. A unique method of 
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obtaining quantitative data using this technique was described 
by Durnan and Palmiter (1983) and involves applying the RNase 
digested reaction directly to glass filters which omits the 
electrophoresis step. The degraded RNA is washed away with 
trichloroacetic acid and the RNA:RNA duplex remains on the 
filter and is counted using a scintillation counter. 
RNase protection assays are more sensitive than membrane 
hybridization techniques. Several assays have been able to 
detect as little as 1 picogram of mRNA in a sample containing 
total RNA (Melton et al., 1984). With this sensitivity, 
extracting mRNA from total RNA preparations is usually not 
necessary. In addition, RNase protection assays do not require 
the time-consuming pre-hybridization and washing steps that 
are associated with membrane hybridization techniques. 
Despite being more sensitive and convenient, RNase 
protection assays can be difficult to develop. The 
hybridization probes must be rigorously tested for specificity 
on northern blots and effective concentrations of the probe 
and sample RNA must be titered. In addition, the hybridization 
and nuclease digestion conditions that are used in the assay 
must be determined empirically, and at present this technique 
is limited to the use of radioactive probes (Sambrook et al, 
1989). Nevertheless, RNase protection assays offer superior 
sensitivity over northern or dot blot techniques and they have 
been extensively used to detect cytokine mRNA molecules 
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(Hagiwara et al, 1987; Hagiwara et al., 1988) 
Reverse Transcription-Polymerase Chain Reaction 
The polymerase chain reaction {PCR) is a powerful 
technique for detecting the presence of specific DNA sequences 
and amplifying specific DNA fragments for subsequent 
analytical manipulations {Saiki et al., 1985). Reverse 
transcription-PCR (RT-PCR) involves reverse transcribing mRNA 
into cDNA and using this molecule as a template in the PCR 
(Kawasaki et al., 1988). RT-PCR is a sensitive method of 
detecting, subcloning, and characterizing specific gene 
transcripts. 
The specificity of the RT-PCR technique is achieved by 
the use of paired sequence-specific oligonuc leotide primers in 
the PCR. The primers range in size from 15 to 30 bases and are 
specific for sequences that are present on the transcript to 
be analyzed. The primers bind to opposing strands of the DNA 
template and allow the amplification of the intervening 
region. Amplification is accomplished by rapidly changing the 
reaction temperature so that template melting, primer 
annealing and DNA polymerization occurs repeatedly. A 
thermostable polymerase is used in the reaction so that the 
activity of the enzyme is not destroyed by the high melting 
temperatures. The results of RT-PCR analysis are obtained by 
electrophoresing an aliquot of the PCR on a gel and detecting 
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the presence or absence of an amplified product by ethidium 
bromide staining (Erlich, 1989). 
The RT-PCR is an extremely sensitive technique and is 
often the method of choice when only small amounts of sample 
are available or when analyzing low abundance transcripts 
(Rappolee et al., 1989). Successful analysis of cytokine mRNA 
isolated from as few as ten cells has been reported (Carding 
et al., 1992). In addition, RT-PCR is a rapid method and 
avoids the time-consuming and cumbersome steps associated with 
membrane hybridization procedures and RNase protection assays. 
Generally, results from RT-PCR can be obtained in one day. 
Because of the exquisite sensitivity of RT-PCR, rigorous 
measures must be taken to avoid contamination of samples and 
reaction mixtures. Sterile and clean reagents, pipette tips 
and reaction tubes must be used, and gloves should be worn 
during all steps of the procedure. Moreover, the PCR should be 
conducted in a room separate from that in which RNA is 
isolated and reverse transcription reactions are conducted. To 
ensure that no contamination has occurred, a negative control 
that does not contain a template should be included in each 
set of reactions (Saiki, 1989). 
Like most other methods of transcript analysis, 
quantitative information is difficult to obtain using RT-PCR. 
In addition to the usual problems of quantifying and 
accurately aliquoting the RNA samples, RT-PCR is subject to 
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tube-to-tube variability in the reverse transcription and 
polymerase chain reactions. Because amplification occurs 
initially at an exponential rate, the slightest differences in 
reaction efficiencies can result in dramatic differences in 
the amount of the final product (Wang et al., 1989). Despite 
this limitation, qualitative and semi-quantitative information 
can be obtained using the RT-PCR, and the convenience and 
sensitivity of this technique still make it an attractive 
method of transcript analysis. 
As with northern blots, the co-amplification of a reverse 
transcribed control mRNA such as B-actin is often used to 
ensure the RNA samples have been accurately aliquoted and 
reverse-transcribed. As with the use of control genes in 
northern blots, the transcription of the control gene in RT-
PCR must be constant under all conditions that are encountered 
in the study. In addition, several methods have been developed 
for quantitating the amount of amplified product that is 
produced in the RT-PCR (Nakayama et al., 1992; Melby et al., 
1993). However, it is difficult to demonstrate that the amount 
of the amplified product is a direct reflection of the amount 
of starting RNA. 
Several investigators have developed modifications of the 
RT-PCR to allow the accurate quantitation of specific cytokine 
mRNA molecules that are contained in RNA samples. All of these 
modifications involve adding to the reverse transcription 
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reaction or PCR a known amount of an internal standard that 
competes for the same primers as the cytokine transcript. The 
product amplified from the standard is a different size than 
the product amplified from the cytokine transcript. The 
standard is diluted and added to a constant amount of test 
RNA. After amplification and electrophoresis, the amount of 
transcript contained in the test sample is determined by 
comparing the amounts of the test transcript product and 
standard transcript product contained on the gel (Kanangat et 
al., 1992; Siebert and Larrick, 1992; Wang et al., 1989; 
Becker-Andre et al., 1989). Although this approach is time-
consuming and difficult to develop, it does result in an 
extremely sensitive and quantitative method of transcript 
analysis. 
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IN SITU ANALYSIS 
All of the methods of cytokine analysis discussed thus 
far have involved assaying materials that have either been 
secreted or extracted from tissue samples or cells. 
Consequently, these methods do not provide any information 
concerning the identity or frequency of the cytokine-producing 
cells. To address these issues, several methods of analyzing 
cytokine production at the single cell level have been 
developed that allow the characterization, enumeration and in 
some cases the anatomical localization of cytokine-producing 
cells. 
Enzyme-linked I:mm.unospot Assay 
The enzyme-linked immunospot assay (ELLISPOT) is a 
modification of the ELISA technique and was first developed 
for enumerating specific antibody-secreting cells (Czerkinsky 
et al., 1983). Modifications of this original protocol 
resulted in a technique that can be used to detect and 
enumerate a variety of antigen-secreting cells (Hutchings et 
al., 1989; Versteegan et al., 1988; Czerkinsky et al., 1988). 
The ELLISPOT technique involves incubating a single-cell 
suspension in a plastic dish or on a nitrocellulose membrane 
that has been coated with the pertinent cytokine-specific 
antibody. The cells are then removed and the cytokines that 
were secreted from the cells during the incubation remain 
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bound to the immobilized antibody. The step-wise addition of 
enzyme-labelled anti-cytokine antibody and enzyme substrate 
results in the appearance of colored spots at the location of 
the formerly plated cytokine-secreting cells. These spots can 
be enumerated under low magnification and the number of 
cytokine-secreting cells contained in the cell suspension can 
be determined (Czerkinsky et al., 1991). 
The ELLISPOT technique has been used to detect and 
enumerate cells producing IFN-y, IFN-a, tumor-necrosis factor 
and IL-lB (Czerkinsky et al., 1991). This method is both rapid 
and easy to perform and uses reagents and techniques that are 
identical to those employed in the conventional ELISA. By 
combining the ELLISPOT with a conventional ELISA Versteegan et 
al., (1988) demonstrated that one spot on the ELLISPOT 
membrane represented approximately 0.01 U of IFN-y activity. 
The ELLISPOT technique has proven especially useful in 
detecting cytokine-producing cells that have been cultured in 
vitro, but it has also been used to analyze cells from biopsy 
specimens (Hutchings et al., 1989; Czerkinsky et al., 1991). 
Two major drawbacks are encountered when using this 
method. The first is that the assay requires long incubation 
times. The conditions encountered by the cells during these 
incubations may modulate their cytokine secretion. The second 
disadvantage is that this technique does not yield any 
information concerning the nature of the cytokine-producing 
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cells since they are removed from the assay before spot 
development (Czerkinsky et al., 1991). Despite these 
limitations, the reverse ELLISPOT offers a sensitive and 
convenient method of detecting and enumerating cytokine-
producing cells in a heterogenous cell population. 
Immunohistochemistry 
Immunohistochemistry is a powerful and widely used 
histologic technique that has found application in research 
and clinical medicine. This technique uses antibodies to 
detect antigens that are located on histologically prepared 
cells or tissues sections. Immunohistochemistry has been most 
extensively used in pathology to localize pathogenic agents in 
tissue samples and to phenotypically and functionally 
characterize cells. The development of cytokine-specific 
antibodies has made this technique easily adaptable to 
studying cytokines that are present in tissues and cells. 
A variety of antibody conjugates and detection systems 
have been used in immunohistochemistry and like the ELISA both 
direct and indirect methods of antibody labelling can be used. 
Peroxidase and alkaline phosphatase antibody conjugates are 
commonly used. When combined with the appropriate substrates, 
these antibody conjugates produce a localized colored product 
that can be seen under microscopic examination. A more direct 
method of visualizing cytokines can be obtained by using FITC 
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or rhodamine conjugates that fluoresce when exposed to UV 
light (Carson, 1990). 
Although inununohistochemical detection of cytokines is a 
commonly used technique in pathology research, it suffers from 
major limitations with respect to the study of cytokine 
production. The first and most important is that 
inununohistochemical demonstration of a cytokine requires that 
it be present in a cell-associated form. Since most all 
cytokines have been shown to be secreted proteins, 
immunohistochemical techniques may grossly underestimate the 
amount of cytokine molecules that have been produced because 
this technique only detects cell-associated cytokines (Hofler 
et al., 1988). Furthermore, this method can not distinguish 
between cells that have produced cytokines and cells that have 
internalized cytokines. This may lead to false-positive 
results concerning the cellular localization of cytokine-
producing cells (Sander et al., 1991). The concurrent analysis 
of cytokine gene transcription or cytokine secretion using 
other techniques can provide supportive information when 
analyzing cytokines by immunohistochemical techniques (Chensue 
et al., 1991; Kasahara et al., 1991). 
Immunohistochemistry does offer two unique capabilities 
that are not found with other cytokine assays. The most 
obvious advantage is that cytokine production can be localized 
to individual cells and specific anatomical compartments, and 
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the proximity of cytokine-producing cells to pathogenic agents 
can be determined (Nickoloff et al., 1991; Arnoldi et al., 
1990). Another attractive advantage is that multiple labelling 
and detection systems can be used on the same sample to allow 
several antigens to be simultaneously detected. This 
capability has many applications including detecting more than 
one cytokine or phenotypically characterizing different 
cytokine- producing cells (Chensue et al., 1991; Nickoloff et 
al. , 1991). 
In Situ Hybridization 
In situ hybridization is a technique that uses the 
principles of hybridization methodology to locate specific 
nucleic acid sequences at the single cell level ( Hofler et 
al., 1988; Coghlan et al., 1985). It was first described as a 
method of locating DNA sequences on isolated chromosomes (Gall 
and Pardue, 1971), and it has since been modified to detect 
mRNA in distinct cell populations (Angerer and Angerer, 1981). 
In situ hybridization is highly ana logous to 
immunohistochemistry in that both techniques look at different 
aspects of the same proc ess; the in situ analysis of gene 
expression. Immunohistochemistry uses specific antibodies to 
detect the protein product of a cytokine gene whereas in situ 
hybridization uses nucleic acid probes to detect the cytokine 
mRNA. The in situ detection of mRNA is a unique and powerful 
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method of transcript analysis that combines high sensitivity 
and specificity with precise anatomic localization. 
The most obvious advantage in using in situ hybridization 
for studying cytokine gene expression is the ability to 
localize a hybridization signal in histologically complex 
tissues. In addition to providing information about the 
cytokine-producing cell, this technique also offers some 
technical advantages. Extracting RNA from tissues is not 
necessary, which eliminates the need for large amounts of 
tissues and the technical skill in handling labile RNA 
preparations. Moreover, the cytokine mRNA molecules of 
interest are not diluted by the mRNA from numerous background 
cells that are not expressing the cytokine gene. Finally, the 
tissue fixation procedures that are used for in situ 
hybridization eliminate much of the health risk that is 
associated with clinical specimens (DeLellis and Wolfe, 1987). 
Combining in situ hybridization with immunohistochemistry 
provides a unique method that allows the detection of cytokine 
and cytokine mRNA molecules in the same tissue (Holfer et al., 
1988; Shivers et al . , 1986). These techniques can be used to 
verify that a cytokine is being synthesized by a cell and that 
the cytokine has not simply been acquired from another source 
(Mielke et al., 1990; Howell et al., 1991). The phenotypic 
characterization of cells expressing cytokine mRNA can also be 
determined (Peuchmaur et al., 1990). Another application of 
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these combined techniques is to locate cytokine gene 
transcripts in relation to the presence of pathogenic agents 
(Arnoldi et al., 1990). The combination of in situ 
hybridizatio n and immunohistochemistry permits unique insights 
into the mechanisms of cytokine gene regulation that are not 
afforded by any currently available method of cytokine 
analysis. 
The major disadvantages associated with in situ 
hybridization is that it is technically demanding and it 
requires knowledge and skill in both histology and molecular 
biology. Despite these many difficulties, in situ 
hybridization offers many advantages over other methods of 
cytokine analysis and it has been widely used in the single-
cell detection of cytokine gene transcription. 
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SUMMARY 
There are many techniques available for studying cytokine 
production and each method has its own capabilities and 
limitations. Bioassays lack specificity but provide 
information about cytokine biological activity. Immunoassays 
are highly specific , but they detect cytokines that may or may 
not be active. Analyzing cytokine mRNA levels gives specific 
information about cytokine gene activation, but does not 
reveal any information about cytokine secretion. Finally, in 
situ methods of cytokine analysis localize cytokine production 
to a single-cell, but these assays are difficult to develop. 
It is apparent that no currently used method of analyzing 
cytokine production provides comprehensive data, and cytokine 
production may need to be evaluated by multiple approaches in 
order to obtain useful information. 
The virtual explosion o f research in cytokine biology in 
the past decade has been facilitated by the development of 
methods to analyze cytokine production. However, it is 
apparent that the continued development of new and improved 
methods and reagents is needed . This is especially true in the 
area of veteri nary research where the study of cytokines in 
domestic animals has been limited by the lack of species-
specific reagents. 
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PAPER II. CLONING BOVINE CYTOKINE cDNA FRAGMENTS AND 
MEASURING BOVINE CYTOKINE mRNA USING THE 
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION 
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ABSTRACT 
Bovine cytokine-specif ic primers and the reverse 
transcription-polymerase chain reaction (RT-PCR) were used to 
clone cDNA fragments that were specific for bovine IL-la, 
IL-18, IL-2, and IFN-y. Specificity of the cDNA fragments was 
verified by sequence analysis based on known bovine IL-la, 
IL-18, IL-2, and IFN-y gene sequences. In addition, RT-PCR was 
used to monitor cytokine rnRNA expression in concanavalin A and 
lipopolysaccharide-stimulated bovine peripheral blood 
mononuclear cells (PBMC) and the results were compared to 
those obtained by measuring PBMC cytokine secretion using 
biologic assays. IL-1 activity in lipopolysaccharide-
stimulated PBMC cultures was similar at 12 and 24 h, although 
the activity decreased by approximately 40% at 48 h. IL-2 and 
IFN-y activity in supernatants of concanavalin A-stimulated 
PBMC cultures was low at 12 h and reached maximum levels at 48 
h. RT-PCR transcript analysis detected an increase in IL-la, 
IL-18, IL-2, and IFN-y rnRNA expression that was usually 
correlated with the detection of these soluble cytokines by 
the bioassays . These results indicate RT-PCR is a sensitive 
and effective method of obtaining cDNA probes and that this 
technique can be used to monitor bovine cytokine rnRNA 
expression. 
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INTRODUCTION 
Biologic assays that use cytokine-dependent cell lines 
provide a very sensitive and quantitative means of measuring 
cytokine production (Gillis et al., 1978; Rubenstein et al., 
1981). However, these assays lack specificity and they only 
detect secreted cytokines and not cytokines that are membrane-
bound or cell-associated. In addition, samples that are 
assayed for a specific cytokine often contain many different 
cytokines that may have a co-stimulatory or an inhibitory 
affect on the indicator cell lines that are used in biologic 
assays (Helle et al., 1988; Grabstein et al., 1986; Ranges, et 
al., 1988). 
Cloning cytokine genes has helped circumvent these 
problems associated with biologic assays by providing species-
specific nucleic acid probes for detecting cytokine gene 
transcripts. Assays using nucleic acid probes are very 
specific and they can be used in a semi-quantitative manner to 
detect the presence or absence of cytokine mRNA. 
The cloning of cytokine genes in cattle has lagged behind 
the cloning of these genes in laboratory animals and humans. 
Sufficient homology occasionally exists between cytokine genes 
of different species to allow the use of heterologous probes 
to detect bovine cytokine mRNA (Jensen and Schultz, 1991; 
Stevens et al., 1992). However, special hybridization and 
washing conditions must be used to compensate for the 
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imperfect homology, which limits the specificity and 
sensitivity of the probes (Sambrook et al., 1989). The 
development of bovine-specific cytokine nucleic acid probes 
would eliminate this problem and provide specific and 
sensitive reagents for studying the bovine immune system. The 
cloning of IL-la, IL-18, IL-2, and IFN-y genes in cattle 
(Maliszewski et al., 1988; Cerretti et al., 1986a; Cerretti et 
al., 1986b) has provided the necessary information for 
developing bovine-specific cytokine nucleic acid probes that 
can be used in assays to monitor bovine cytokine gene 
transcription. 
The polymerase chain reaction (PCR) is a powerful 
technique for detecting the presence of specific DNA sequences 
and amplifying specific DNA fragments for subsequent 
analytical manipulations (Saiki et al., 1988). Reverse 
transcription-PCR (RT-PCR) involves reverse transcribing mRNA 
into cDNA and using this molecule as a template in the PCR 
(Kawasaki et al ., 1988). RT-PCR is a sensitive method of 
detecting, subcloning , and characterizing specific gene 
transcripts. 
This paper describes using the RT-PCR and bovine 
cytokine-specif ic primers to amplify and clone cDNA fragments 
that are specific for bovine IL-la, IL-18, IL-2, and IFN-y . 
RT-PCR was also used to detect bovine cytokine transcripts in 
mitogen-stimulated peripheral blood mononuclear cells (PBMC) 
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and the results were compared to those obtained by measuring 
PBMC cytokine secretion using biologic assays. 
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MATERIALS AND METHODS 
Cattle and Isolation of PBMC 
Four 3-year old non-pregnant Holstein cows were used in 
this study. Blood was obtained by jugular venipuncture and 
PBMC were isolated by density gradient centrifugation (400 x 
g, 30 min) using Histopaque 1083 (Sigma, st . Louis, MO) . The 
PBMC were washed twice in phosphate buffered saline by 
centrifugation and placed in RPMI 1640 medium (Gibco BRL, 
Grand Island, NY) containing 25 mM hepes, 2 mM L-glutamine, 5 % 
fetal bovine serum (Hyclone, Logan, UT), 5 x 1 0-5 MB-
mercaptoethanol, 100 U/ml penicillin, and 100 µg/ ml 
streptomycin. This supplemented medium is subsequently called 
RPMI. 
RNA Extraction from Mitogen Stimulated Bovine PBMC 
PBMC obtained from individual cows were incubated for 17 
h (37 °C in 5 % C02 ) in 100 ml of RPMI media (1 x 10
6 cells/ ml) 
alone and in RPMI containing either 1 µg/ ml concanavalin A 
( Con A; Sigma, St. Louis, MO ) or 10 µg/ ml Escherichia coli 
055 : B5 lipopolysaccharide (LPS;Sigma). After 17 h of 
incubation, total RNA was isolated from each culture by 
extraction with guanidine isothiocyanate as described 
(Chomczynski and Sacchi, 1987 ). 
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Amplification of Bovine cytokine cDHA Fragments 
An aliquot of each PBMC RNA sample containing 5 µg of 
total RNA was added to a separate tube, precipitated with 
ethanol, and resuspended in 10 µl diethyl pyrocarbonate 
( DEPC)-treated sterile distilled water. 500ng oligo(dt) 15 
primers (Promega, Madison, WI) were added and the mixture was 
heated at 70 °C for 10 min followed by a quick-chill on ice. 
The samples were reverse-transcribed in a 20 µl reaction 
mixture containing lX reverse transcription buffer (50 mM 
Tris-HCl pH 8.3, 75 rnM KCl, 3 rnM MgCl ) , 50 mM dithiothrietol, 
dATP, dCTP, dTTP, and dGTP each at 125 nM, and 200 units 
Moloney murine leukemia virus RNase H- reverse transcriptase 
(Superscript, Gibco BRL, Gaithersberg, MD). The mixture was 
i ncubated at 3 7 ° C for 1 h followed by a 5 min i ncubation at 
95 °C. 
Four µl of each of the resulting reverse transcription 
reactions was used as a template in a 100 µl PCR that 
consisted of lX PCR reaction buffer (10 rnM Tris-HCl pH 8 . 3, 50 
rnM KCl, 1 . 5 rnM MgCL2, .001% g e latin), dATP, dCTP, dGTP and 
dTTP each at 200 µM, 2.5 U ArnpliTaq DNA Polymerase (Perkin 
Elmer Cetus, Norwalk, CT), and 200 ng each of the upstream and 
downstream PCR primers for the appropriate bovine cytokine 
(Table I ) . Bovine cytokine-speci fic primers were 20 base 
oligonucleotides and were chosen so that they span the coding 
region of the cytokine transcripts based on the published 
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Table I 
Nucleotide Sequence of upstream and downstream PCR primers for 
bovine IL-la, IL-lB, IL-2, and IFN-y 
Cytokine Oligonucleotide 
IL-la (sense) 5'ATGGCCAAAGTCCCTGACCT 
(anti-sense) 5'CGTCTTCATTTTGAGCACTC 
IL-18 (sense) 5'CTACAGTGACGAGAATGAGC 
(anti-sense) 5'GGAAGTAGACCCCAAAGTCT 
IL-2 (sense) 5'AGATACAACTCTTGTCTTGC 
(anti-sense) 5'AGTCATTGTTGAGTAGATGC 
IFN-y (sense) 5'CTGATCATAACACAGGAGCT 
(anti-sense) 5'GACCATTACGTTGATGCTCT 
3 ' 
3' 
3 I 
3' 
3' 
3 I 
3' 
3' 
Predicted 
Product(bp) 
596 
566 
457 
564 
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sequences for bovine IL-la, IL-18 (Maliszewski et al., 1988), 
IL-2 (Cerretti et al., 1986a), and IFN-y (Cerretti et al., 
1986b) cDNAs (Figure 1). IFN-y and IL-2 cDNA were amplified 
from reverse transcribed RNA that was obtained from Con A-
stimulated PBMC. The IL-la amd IL-18 cDNA was amplified from 
reverse transcribed RNA that was obtained from LPS-stimulated 
PBMC. Cycling parameters for all primer sets were a presoak 
at 95 °C for 5 min followed by 35 cycles of 95 °C for 1 min, 
37 °C for 1 min, and 72 °C for 2 mi n. Af ter 35 cycles, the 
reactions were incubated for 72 °C for 5 mi n. Aliquots of each 
PCR were analyzed by electrophoresis usi ng a 1 . 5 % agarose gel. 
Cloning Bovine Cytokine cDNA Fragments 
The amplified produc ts were c l oned into the PCR cloni ng 
vector PCRlOOO (Invitrogen, San Diego, CA ) according to the 
manufacturers instructions . Briefly, the unpurified PCR 
product was ligated into the PCRlOOO cloning vector and the 
ligation products were transf or med i nto competent .IL.. coli 
strain INVa (Invitrogen, San Di ego, CA) by standard 
procedures. Putative clones were initial l y screened by 
restriction analysis. Positive clones were confirmed by 
sequence analysis using an Applied Biosystems Model 373A 
automated DNA sequencer by the Iowa State University Nucleic 
Acid Facility (Ames, IA). The bovine cytokine cDNA f ragments 
were then subcloned into pGEM-4Z(+) using standard procedures 
Fig. 1. Partial restriction map of the bovine IFN-y (A), IL-la 
(B), IL-2 (C), and IL-lB (D) cDNA. The open box 
represents the coding region for the precursor 
protein and the shaded box represents the coding region 
for the mature protein. The location of the upstream 
and downstream PCR primers are indicated under each map 
with a .. along with the numerical base position from 
the published sequence ( Cerretti et al, 1986b; 
Maliszewski et al., 1988; Cerri tti et al, 1986a). 
The size of the amplified fragment is indicated in base 
pairs (bp). 
A. 
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(Promega, Madison, WI). 
Probe Generation by In Vitro Transcription 
Labelled single stranded RNA probes specific for the 
bovine cytokine cDNA inserts were generated by producing run 
off transcripts from the pGEM(-4z) vector as described by the 
manufacturer. Vector DNA was removed by digestion with RQ 1 
RNase-free DNase (Promega, Madison, WI) at 1 U/ µg of template 
DNA. The undigested RNA transcripts were purified by Sephadex 
G-50 spin column chromatography (5 Prime-.3 Prime, Inc., 
Boulder, co). 
Incubation of Bovine PBMC with Con A and LPS 
PBMC from the four holstein cows were incubated for 12, 
24, and 48 h in RPMI medium (1 x 106 cells/ ml) alone, and in 
RPMI containing either Con A (1 µg/ ml) or .E_._ coli 055:B5 LPS 
(10 µg/ml). Cells from the c ultures were harvested by 
centrifigation for subsequent mRNA extraction. Culture 
supernatants were removed and stored at - 70° C until assayed 
for IL-1, IL-2, and IFN-y activity using biologic assays. 
Analysis of Bovine Cytokine Transcripts in Con A- and LPS-
stimulated PBMC 
PBMC mRNA was extracted by guanidinium isothiocyanate 
extraction and oligo(dt) cellulose chromatography as described 
(Chomczynski, 1987, Aviv and Leder, 197 2 ). The mRNA (0.5 µg) 
from each extraction was reverse transcribed as described for 
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total RNA, diluted (1:100), and 4 µl was used as a template in 
the PCR with bovine cytokine specific primers for IL-la, IL-
lB, IL-2, and IFN-y. Identical cycling parameters were used as 
described for total RNA except the annealing temperature for 
the IL-la and IFN-y reactions was elevated to 53 °C. A positive 
control consisting of a PCR using the recombinant plasmid 
containing the relevant cDNA insert and a no-template negative 
control were included in each analysis. Aliquots of each PCR 
were analyzed by electrophoresis using a 1.5% agarose gel. 
Southern Blot Analysis 
For Southern blot analysis of amplified bovine IL-la , IL-
lB, IL-2 and IFN-y cDNA fragments, 5 µl of the PCR products 
that were amplified from reverse transcribed PBMC mRNA were 
electrophoresed on a 1.5% agarose gel. The gel was 
photographed under UV illumination and transferred to a nylon 
membrane (Nytran, Schleichler and Schuell, Keene, NH) by 
capillary action using 20X SSC ( 3 M NaCl, 0.3M Na2citrate pH 
7.0) as the ascending buffer. After baking (80 °C for 30 min), 
the membrane was pre-hybridized for 30 min at 50 °C in a 
hybridization buffer containing 50% formamide, l.5X SSPE (0 . 2 
M NaCl, 15 mM NaH2 Po., 2 mM EDTA), 1% sodium dodecyl sulfate 
(SOS), 0.5% non-fat dry milk, 200 µg/ml yeast tRNA, and 
500µg/ ml herring sperm DNA. After 30 min, 1 x 106 cpm/ml of 
the relevant cRNA probe (specific activity approximately 1 x 
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109 cpm/µg) was added directly to the pre-hybridization 
solution, and hybridization was performed at 60°C for 24 h. 
The post-hybridization washes consisted of two washes for 30 
min each at room temperature. The first wash was in 2X SSPE 
containing 0.1% SDS, and the second was in 0 . 5X SSPE 
containing 0.1% sos. The final wash was for 30 min at 60 °C in 
O.lX SSPE containing 0.1% sos. For autoradiography, the 
filter was exposed to X-ray film (X-OMAT film, Kodak, 
Rochester, NY) at -70°C for 4 h before development. 
IL-1, IL-2, and IFN-y Assay 
Secretion of IL-1 and IL-2 by bovine PBMC was quantitated 
by measuring proliferation of an IL-1-dependent (300Bl cells) 
and an IL-2-dependent (300L2) bovine T cell line as described 
(Stevens and Olsen, 1993). Briefly, proliferation was measured 
by uptake and incorporation of 3 H-methyl-thymidine. The 
proliferative responses (counts per minute) were then 
converted to units of IL-1 and IL-2 by probit analysis using 
recombinant bovine IL-lB (American Cyanamid, Princeton, NJ) 
reacted with the 30081 cells and recombinant bovine IL-2 
(American Cyanamid) reacted with the 300L2 cells as a 
reference standard. Concentrations of IFN-y in bovine PBMC 
culture supernatants were quantitated by measuring the 50% 
reduction of the cytopathic effects of vesicular stomatitis 
virus on Madin-Darby bovine kidney cells as described (Stevens 
74 
and Olsen, 1993). Briefly, the IFN-y titer was calculated as 
the reciprocal of the supernatant dilution that protected 50% 
of the kidney cells from virus-induced lysis. Incubation of 
recombinant bovine IFN-y (Ciba- Giegy, Basel, Switzerland) with 
virus-infected kidney cells was used as a positive control. 
75 
RESULTS 
Amplification and Cloning of Bovine cDNA Fragments for IL-la, 
IL-16, IL-2, and IFN-y 
Our strategy for cloning nucleic acid probes for bovine 
IL-la, IL-lB, IL-2, and IFN-y involved using the PCR and 
paired oligonucleotide primers that were specific for bovine 
cytokine genes to amplify and clone the cDNA fragments. 
Reverse transcribed mRNA from mitogen-stimulated PBMC served 
as the template. The oligonucleotides used in this study 
(Table 1) were derived from the published gene sequences for 
bovine IL-la, IL-lB, IL-2, and IFN-y. A partial restriction 
map of the bovine cytokine cDNA's with the position of the 
paired PCR primers is presented in Figure 1. The predicted 
sizes of the amplification products are given below each map. 
RT-PCR performed on reversed transcribed RNA from 
mitogen-stimulated PBMC using bovine IL-la, IL-lB, IL-2, and 
IFN-y primers resulted in 596, 457, 566 and 564bp 
amplification products, respectively (Figure 2). Some non-
specific amplification occurred using the IL-la and IFN-y 
primers in both stimulated and unstimulated samples, but the 
predominant products in the mitogen-stimulated samples were of 
the predicted size. This non-specific amplification was 
eliminated in subsequent reactions by raising the annealing 
temperature from 37 °C to 53 °C (data not shown). 
The putative bovine IL-la, IL-lB, IL-2, and IFN-y 
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Fig . 2. Amplification of reverse transcribed total RNA from 
unstimulated and mitogen-stimulated bovine PBMC using 
bovine IL- lB, IL-la, IL-2, and IFN-y specific 
primers . 
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amplification products were cloned into PCRlOOO (Invitrogen, 
San Diego, CA) and the clones were initially screened by 
restriction analysis. Clones shown to contain the correct IL-
la, IL-18, IL-2, and IFN-y inserts by restriction analysis, 
were sequenced for confirmation. Sequence analysis revealed 
that the PCR generated fragments were identical to the 
published sequences with the exception of two purine-
pyrimidine transversions at base position 394 of the IL-la 
insert (data not shown). 
In Vitro Transcription of cRNA Probes 
In vitro transcription was used to generate single-
stranded RNA molecules that were specific for the bovine 
cytokine cDNA inserts. This is made possible by the opposing 
RNA polymerase initiation sites (Sp6 and T7) that flank the 
multiple cloning site of the pGEM-4Z vector. A typical 
labelling reaction yielded approximately 35 ng of RNA with a 
specific activity of 3 x 109 cpm/ µg. 
Comparative Analysis of Measuring IL-1 by a Biologic Assay and 
by IL-la and IL-18 Transcript Analysis Using RT-PCR 
IL-1 activity in LPS-stimulated PBMC cultures was similar 
at 12 and 24 h, although the activity decreased by 
approximately 40% at 48 h (Figure 3A). Virtually no IL-1-like 
activity was detected in cultures of unstimulated PBMC at each 
time point. RT-PCR analysis indicated elevated levels of IL-la 
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transcripts at 12 and 24 h after incubating PBMC with LPS. 
However, only trace amounts of IL-la transcripts occurred at 
48 h (Figure 4A). A low, but constant level of IL-la 
transcript was detected in unstimulated PBMC, which decreased 
to barely detectable levels at 48 h. In contrast, IL-lB 
transcripts were detected by RT-PCR at all time points in LPS-
stimulated and unstimulated PBMC (Figure 4B). There was a 
slight decrease in the amount of IL-lB mRNA detected in 
unstimulated PBMC at 12 and 48 h. 
Comparative Analysis of Measuring IL-2 by a Biologic Assay and 
by IL-2 Transcript Analysis Using RT-PCR 
IL-2 activity in supernatants of Con A-stimulated PBMC 
cultures was low at 12 h and reached maximum activity at 24 to 
48 h (Figure 3B). Similarly, RT-PCR analysis showed that high 
levels of IL-2 message were present at 24 and 48 h, although 
it did not detect any message at 12 h (Figure 4C). No IL-2 
transcripts were amplified in the unstimulated PBMC at all 
three incubation periods. 
Comparative Analysis of Measuring IFN-y by a Biologic Assay 
and by IFN-y Transcript Analysis using RT-PCR 
IFN-y activity in PBMC culture supernatants was observed 
to progressively increase at 12 and 24 h and reached maximum 
levels at 48 h after incubation of PBMC with Con A (Figure 
3C). IFN-y mRNA was detected by the RT-PCR at 24 and 48 h, but 
not at 12 h after incubating PBMC with Con A (Figure SD). 
Fig. 3. Secretion of IL-1, IL-2, IFN-y by mitogen-stimulated 
bovine PBHC. Cells (1 x 106 / ml) were incubated alone or 
wi th LPS ( 10 µg/ ml) or Con A (1 µg/ml). Cell-free 
supernatants were harvested at 12, 24, and 48 h after 
i ncubation. IL-1 activ ity (A) was assayed in 
supernatants from LPS- stimulated PBHC. IL-2 (B) and 
I FN-y ( C) activity was assayed in supernatants from Con 
A-stimulated PBHC. Results are presented as means ±SD. 
(n=4) . 
N 
...J 
!? ·c: 
=> 
- LPS 
30 
20 
tO 
0 
12 Houra 
25 -Unstimulated 
20 L... m con A 
15 - T 
10 ~ 
5 -
0 
12 [ - U"'tlm•latod 
10 Im Con A 
8 ~ 
I 
0 
l 2 Hours 
80 
24 Hours 
Incubation 
T 
24 Hours 
Incubation 
24 Hours 
Incubation 
A 
48 Hours 
B 
48 Hours 
c I 
Fig. 4. Analysis of IL-la, IL-18, IL-2, and IFN-y m.RNA 
expression in mitogen-stimulated bovine PBMC by RT-PCR. 
Cells (1 x 106 /ml) were incubated alone or with LPS (10 
µg/ml) or Con A (1 µg/ ml). At 12, 24, and 48 h after 
incubation, PBMC mRNA was isolated, reversed 
transcribed, and then amplified by PCR using bovine 
cytokine-specific primers. IL-la (A) and IL-18 (B) mRNA 
were measured in LPS-stimulated PBMC. IL-2 (C) and 
IFN-y (D) mRNA were measured in Con A-stimulated PBMC. 
Lanes marked (-) are a no template negative control. 
Lanes marked (+) are a positive control in which a 
plasmid containing the cloned cytokine cDNA fragment 
was used as the PCR template. The presented analyses 
are representative of the results that were obtained 
from analyzing mitogen-stimulated PBMC samples from 4 
cattle. 
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IFN-y mRNA was also detected at low levels in the unstimulated 
PBMC at all three incubation periods. 
Southern Blot Analysis 
A Southern blot using the cloned IL-la cDNA insert as a 
probe showed that the amplified products in the IL-la RT-PCR 
was specific for IL-la (Figure 5). Southern blots using the 
cloned IL-lB, IL-2, and IFN-y cDNA inserts as probes also 
confirmed the specificity of the amplified products in the IL-
lB, IL-2, and IFN-y RT-PCR (data not shown) . 
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I II II II I 
Control 12h 24h 48h 
Fig . 5. Southern blot of RT-PCR analysis for bovine IL-la. 
The gel from Figure 4A was transferred to a nylon 
membrane and hybridized to a [ 32P] labelled probe that 
was specific for bovine IL-la. 
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DISCUSSION 
The limited availability of reagents that are specific 
for cytokines in cattle has hampered cytokine research in this 
species. In an effort to overcome this limitation, we describe 
using bovine cytokine specific primers and RT-PCR to develop 
cDNA probes that are specific for bovine IL-la, IL-18, IL-2, 
and IFN-y. RT-PCR was also used to evaluate bovine cytokine 
mRNA expression and these results were compared to measurement 
of cytokine secretion by using biologic assays. 
To ensure that sufficient template was available for 
amplification in the PCR, the PBMC used in this study were 
stimulated with Con A or LPS to induce production of cytokine 
transcripts. After incubating PBMC for 17 h with mitogens, 
PCR products of the predicted size for IL-la, IL-18, IL-2, and 
IFN-y were amplified from reverse-transcribed total RNA as 
detected by gel electrophoresis and ethidium bromide staining. 
These transcripts were inducible because no product was 
amplified in unstimulated PBMC in the IL-2 and IFN-y reactions 
and only trace amounts of the IL-la and IL-lB product were 
amplified from unstimulated PBMC. The non-specific 
amplification that occurred using the IFN-y and IL-la primer 
sets did not prevent the cloning of the IFN-y and IL-la 
fragments, and these ambiguous products were eliminated in 
subsequent reactions by elevating the annealing temperature in 
the PCR to 53°C. 
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The oligonucleotide primer pairs used in this study were 
chosen so that they were specific for the cDNA of interest and 
spanned at least one intron of the genomic sequence. This 
allowed the product amplified from the reverse-transcribed 
mRNA template to be distinguished from the product that would 
be amplified from contaminating genomic DNA, since the latter 
product would be larger in size. 
The utility of RT-PCR in transcript analysis has been 
demonstrated in numerous studies investigating murine and 
human gene expression. More recently, Heussler et al. (1992) 
used this technique to monitor IL-2 transcript levels in 
Theileria parva-infected bovine cells. RT-PCR is an appealing 
method of transcript analysis because semi-quantitative and 
specific results can be quickly obtained from a minimal amount 
of starting material (Carding et al., 1992; Trout and Kelso, 
1992). Despite these advantages, data obtained from 
transcript analysis must be interpreted with caution since the 
presence of cytokine rnRNA may not correlate with the 
translation and secretion of a functional product (Garret et 
al., 1987, Chantry, et al., 1989). 
In the current study, measurement of soluble cytokines by 
biologic assays was correlated with the detection of cytokine 
mRNA by RT-PCR, although discrepancies in the two assays 
occurred at some time points. For example, the biologic assays 
detected IL-2 and IFN-y when PBMC were incubated for 12, 24, 
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and 48 h with Con A. However, RT-PCR revealed that IL-2 and 
IFN-y transcripts were not present at 12 h, although they were 
present at 24 and 48 h. Transcription and secretion of human 
and bovine IL-2 and human IFN-y by mitogen-stimulated 
lymphocytes has been shown to occur in a biphasic pattern, 
with the first peak of transcriptional activity occurring at 
approximately 1 to 1.5 h after stimulation {Grabstein et al., 
1986; Weinberg, et al., 1988). It is not known whether a 
similar biphasic response curve occurred in the present study 
since the first time point of analysis was at 12 h after 
mitogenic stimulation. However, an early and transient peak of 
IL-2 and IFN- y production could account for the detection of 
IL-2 and IFN-y activity in culture supernatants at 12 h in the 
absence of IL-2 and IFN-y transcripts. 
Another possible explanation for the descrepencies 
between the biologic assays and the RT-PCR analysis for IL-2 
and IFN-y is that the biologic assays lacked specificity. The 
specificity of the biologic assays have been examined in a 
previous study that has shown neutralizing antibody to bovine 
IL-2 inhibits about 65 to 80% of the activity detected in the 
IL-2 assay and that by acid treatment IFN-y accounts for about 
80 to 90% of the activity that is detected in the IFN-y assay 
{Stevens and Olsen, 1993 ). Therefore, the IL-2 and IFN-y 
bioassays that were used in the current study primarily 
measure these cytokines, although neither assay is highly 
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specific. 
The 300Bl cells that were used in the biologic IL-1 assay 
will respond to both IL-la and IL-lB (Stevens et al., 1992) 
and these cells can not discriminate between these two 
cytokines (Stevens and Olsen, 1993). The IL-1 assay detected 
soluble IL-1 in supernatants of PBMC at 12, 24, and 48 h after 
incubation with LPS. The RT-PCR analysis revealed that both 
IL-la and IL-18 transcripts were present at 12 and 24 h, and 
that IL-18 but not IL-la transcripts were present at 48 h 
after incubating PBMC with LPS. Therefore, IL-1 activity in 
LPS-stimulated PBMC culture supernatants was correlated with 
the appearance of either PBMC IL-la or IL-18 transcripts. 
Both IL-la and IL-18 transcripts were detected in 
unstimulated PBMC in the absence of secreted IL-1 activity. 
Schindler et al. (1990) has demonstrated that adhering human 
PBMC to glass or plastic results in the expression of IL-lB 
mRNA without detectable IL-18 synthesis. It is currently not 
known whether adherence to plastic or glass stimulates bovine 
PBMC in a similar manner. However, this would account for the 
descrepencies seen between the IL-1 biologic assay and the IL-
la and IL-18 RT-PCR transcript analysis for unstimulated PBMC 
in the present study since the bovine PBMC were cultured in 
plastic flasks. 
The specificity of transcript anlysis by RT-PCR was 
clearly demonstrated in the current study when results of the 
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RT-PCR analysis for IL-la and IL-lB mRNA were compared with 
results of the IL-1 bioassay. The bioassay could not 
discriminate between IL-la and IL-lB activity, yet transcript 
analysis revealed that these two cytokine genes were regulated 
differently in LPS-stimulated bovine PBMC. Transcripts for IL-
la and IL-lB were present at 12 and 24 h, but at 48 h only IL-
lB transcripts were present when PBMC were incubated with LPS. 
These differences in IL-la and IL-lB gene regulation could be 
detected by RT-PCR, but they could not be detected by the IL-1 
bioassay. 
In summary, bovine cytokine specific primers and RT-PCR 
were used to produce bovine cytokine cDNA probes and to detect 
cytokine transcripts in mitogen-stimulated bovine PBMC. RT-PCR 
detected cytokine transcripts in a specific and semi-
quantitative manner and these results were usually correlated 
with secretion of active cytokines. Analysis of cytokine mRNA 
expression by RT-PCR may be useful in studying cytokine 
production by bovine immune cells. In addition, the RT-PCR 
technique conceivably could be used to measure bovine cytokine 
mRNA expression for any gene that has been sequenced. 
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GENERAL SUMMARY 
There are many techniques available for studying cytokine 
production and each method has its own capabilities and 
limitations. It is apparent that no currently used method of 
analyzing cytokine production provides comprehensive data, and 
cytokine production may need to be evaluated by multiple 
approaches in order to obtain useful information. 
The virtual explosion of research in cytokine biology in 
the past decade has been facilitated by the development of 
methods to analyze cytokine production. However, it is 
apparent that the continued development of new and improved 
methods and reagents is needed. This is especially true in the 
area of veterinary research where the study of cytokines in 
domestic animals has been limited by the lack of species-
specific reagents. 
In an effort to overcome this limitation, we describe 
using bovine cytokine specific primers and RT-PCR to develop 
cDNA probes that are specific for bovine IL-la, IL-lB, IL-2, 
and IFN-y. RT-PCR was also used to evaluate bovine cytokine 
mRNA expression and these results were compared to measurement 
of cytokine secretion by using biologic assays. RT-PCR 
detected cytokine transcripts in a specific and semi-
quantitative manner and these results were usually correlated 
with secretion of active cytokines. Analysis of cytokine mRNA 
expression by RT-PCR may be useful in studying cytokine 
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production by bovine immune cells. The RT-PCR technique 
conceivably could be used to generate nucleic acid probes and 
measure mRNA expression for any gene that has been sequenced. 
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